window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 24, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Partnerships & Funding

  • Biotech,CDMOs & Manufacturing,Clinical Development,Clinical Trials,Partnerships & Funding

    Evestia Clinical acquires ICRC-Weyer to expand full-service clinical research in Europe

    Evestia Clinical has acquired Berlin-based CRO and scientific consultancy ICRC-Weyer [...]

    January 29, 2026
  • Biotech,Drug Development,Partnerships & Funding,Rare Diseases,Technology and platforms

    Mendra launches with $82 million Series A to develop rare disease therapies

    Mendra, Inc. has launched with the closing of an $82 [...]

    January 23, 2026
  • Biotech,Drug Development,Global health,Partnerships & Funding,RNA Therapeutics

    Hongene Biotech receives Gates Foundation grant for patent-free mRNA cap analogs

    Hongene Biotech has received a grant from the Gates Foundation [...]

    January 22, 2026
  • Biotech,Drug Development,Immunology,Partnerships & Funding,Research & Development

    Resolve M Therapeutics exits stealth with pro-resolution immunology platform concept

    Resolve M Therapeutics has announced its exit from stealth as [...]

    January 22, 2026
  • Chronic diseases,Drug Development,Obesity,Partnerships & Funding,Pharmaceuticals and therapeutics,Research & Development

    Corxel raises $287 million Series D1 to advance oral GLP-1 candidate CX11

    CORXEL has completed a Series D1 financing of up to [...]

    January 23, 2026
  • Artificial Intelligence,Biotech,Clinical Development,Clinical studies,Drug Development,Partnerships & Funding,Pharmaceuticals and therapeutics,Research & Development

    Immunai partners with Bristol Myers Squibb to apply immune system AI in clinical development

    Artificial Intelligence, Biotech, Clinical Development, Clinical studies, Drug Development, Partnerships [...]

    January 16, 2026
  • Digital Health,Neurosciences,Partnerships & Funding,Women's Health

    Ultrahuman and Click Therapeutics partner on FDA-authorized digital migraine tool

    Ultrahuman and Click Therapeutics have entered a partnership to develop [...]

    January 15, 2026
  • European biotech,Partnerships & Funding,Research & Development,Technology and platforms

    Novo Nordisk Foundation commits DKK 5.5BN (EUR 736M) to BioInnovation Institute expansion

    The Novo Nordisk Foundation has committed up to DKK 5.5 [...]

    January 14, 2026
  • Artificial Intelligence,Drug Development,European biotech,Partnerships & Funding,Technology and platforms

    FluoSphera raises €1.23 million to scale human-based preclinical testing platform

    Swiss biotech startup FluoSphera has raised €1.23 million (CHF 1.15 [...]

    January 12, 2026
  • Biologics & Biosimilars,Biotech,Immunology,Partnerships & Funding,Research & Development

    TECregen raises CHF 10m (EUR 10.7m) seed financing and appoints Dr Bo Rode Hansen as chairman

    TECregen, a biotechnology company focused on thymus regeneration, has completed [...]

    January 8, 2026
Previous345Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Currax highlights peer-reviewed review supporting combination approaches in obesity treatment
    Categories: Obesity, Pharmaceuticals and therapeutics, Research & Development
  • MaaT Pharma publishes real-world CHRONOS data in third-line acute GvHD
    Categories: Clinical Development, Clinical studies, Hematology, Regulatory Affairs, Research & Development
  • Symbiosis expands QC capabilities with new 30°C stability chamber
    Categories: CDMOs & Manufacturing, Facilities and infrastructure, Manufacturing, Pharmaceuticals and therapeutics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top